Preliminary results from a randomized, phase II trial have shown that the transdermal estrogen patch Fem7 ® (Merck KGaA, Darmstadt, Germany) can suppress testosterone to castrate levels in men ...

Transdermal exogenous testosterone improves libido in postmenopausal women receiving estrogen therapy ... administered via skin patches, results in a modest but clinically important increase ...

during the screening period were randomised to receive either oral CEE 0.3 mg/day or an estradiol patch delivering 0.025 mg/day for 12 weeks. Patients were assessed after three 28-day cycles.

When it comes to menopause relief, estrogen patches have proven to be a game changer for many people. Boasting numerous ...